Richard Close
Stock Analyst at Canaccord Genuity
(4.57)
# 995
Out of 4,703 analysts
648
Total ratings
49.3%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintained: Buy | $16 | $10.94 | +46.25% | 25 | Sep 3, 2026 | |
| TDOC Teladoc Health | Maintained: Buy | $10 | $6.28 | +59.24% | 78 | Aug 31, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $30 → $33 | $25.07 | +31.63% | 12 | Aug 31, 2026 | |
| HCAT Health Catalyst | Downgraded: Hold | $3 → $1.8 | $1.69 | +6.51% | 34 | Aug 21, 2026 | |
| DCGO DocGo | Maintained: Hold | $1 | $0.4027 | +148.32% | 21 | Aug 18, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $10 | $6.49 | +54.08% | 31 | Aug 11, 2026 | |
| PGNY Progyny | Maintained: Buy | $35 | $25.94 | +34.93% | 22 | Aug 11, 2026 | |
| CLOV Clover Health Investments | Maintained: Buy | $5.5 | $4.26 | +29.26% | 31 | Aug 11, 2026 | |
| OMDA Omada Health | Maintained: Buy | $28 | $22.77 | +22.97% | 12 | Aug 11, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 → $6 | $4.32 | +38.89% | 80 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 → $43 | $38.43 | +11.89% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $20.66 | +54.89% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $36 | $26.35 | +36.62% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $12.73 | +2.12% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $29 | $29.20 | -0.68% | 64 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $92.37 | +13.67% | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $150.76 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $83 | $57.66 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $4.81 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $24.21 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $38.37 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $259.23 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $247.18 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $9.30 | n/a | 1 | Nov 23, 2009 |
Phreesia
Sep 3, 2026
Maintained: Buy
Price Target: $16
Current: $10.94
Upside: +46.25%
Teladoc Health
Aug 31, 2026
Maintained: Buy
Price Target: $10
Current: $6.28
Upside: +59.24%
Waystar Holding
Aug 31, 2026
Maintained: Buy
Price Target: $30 → $33
Current: $25.07
Upside: +31.63%
Health Catalyst
Aug 21, 2026
Downgraded: Hold
Price Target: $3 → $1.8
Current: $1.69
Upside: +6.51%
DocGo
Aug 18, 2026
Maintained: Hold
Price Target: $1
Current: $0.4027
Upside: +148.32%
AdaptHealth
Aug 11, 2026
Maintained: Buy
Price Target: $10
Current: $6.49
Upside: +54.08%
Progyny
Aug 11, 2026
Maintained: Buy
Price Target: $35
Current: $25.94
Upside: +34.93%
Clover Health Investments
Aug 11, 2026
Maintained: Buy
Price Target: $5.5
Current: $4.26
Upside: +29.26%
Omada Health
Aug 11, 2026
Maintained: Buy
Price Target: $28
Current: $22.77
Upside: +22.97%
Evolent Health
Aug 10, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $4.32
Upside: +38.89%
Aug 10, 2026
Rated: Buy
Price Target: $37 → $43
Current: $38.43
Upside: +11.89%
Aug 7, 2026
Maintained: Buy
Price Target: $34 → $32
Current: $20.66
Upside: +54.89%
Aug 7, 2026
Rated: Buy
Price Target: $30 → $36
Current: $26.35
Upside: +36.62%
Aug 6, 2026
Maintained: Buy
Price Target: $13
Current: $12.73
Upside: +2.12%
Aug 5, 2026
Maintained: Hold
Price Target: $27 → $29
Current: $29.20
Upside: -0.68%
Aug 5, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $92.37
Upside: +13.67%
Mar 10, 2023
Maintained: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Hold
Price Target: $110
Current: $150.76
Upside: n/a
May 12, 2022
Maintained: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Hold
Price Target: $89 → $83
Current: $57.66
Upside: n/a
Nov 8, 2021
Maintained: Buy
Price Target: $18 → $21
Current: $4.81
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $22 → $24
Current: $24.21
Upside: n/a
Feb 22, 2019
Maintained: Hold
Price Target: $33
Current: $38.37
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $259.23
Upside: n/a
Nov 18, 2010
Maintained: Hold
Price Target: n/a
Current: $247.18
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $9.30
Upside: n/a